MNOV MEDICINOVA INC revenue, earnings and financials
For the quarter ended June 30, 2026, MEDICINOVA INC reported revenue of $458K (up 240.6% from a year earlier), net income of −$2.31M and diluted EPS of −$0.05; for the fiscal year ended December 2025 revenue was $410K.
MNOV annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $410K, gross profit n/a, operating income −$13.3M, net income $12.0M (margin 2928.8%), EPS −$0.24
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$12.7M, net income $11.1M (margin n/a), EPS −$0.23
- Fiscal year ended Dec 2023: revenue $1.00M, gross profit n/a, operating income −$9.90M, net income $8.57M (margin 857.2%), EPS −$0.17
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$14.6M, net income −$14.1M (margin n/a), EPS −$0.29
- Fiscal year ended Dec 2021: revenue $4.04M, gross profit n/a, operating income −$10.2M, net income −$10.1M (margin -251.0%), EPS −$0.21
MNOV quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $458K (up 240.6% year over year), net income −$2.31M, EPS −$0.05
- Quarter ended Mar 31, 2026: revenue $187K, net income −$2.59M, EPS −$0.05
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income $21.2M, EPS −$0.05
- Quarter ended Sep 30, 2025: revenue $123K, net income −$3.05M, EPS −$0.06
- Quarter ended Jun 30, 2025: revenue $135K, net income −$3.28M, EPS −$0.07
- Quarter ended Mar 31, 2025: revenue n/a, net income −$2.86M, EPS −$0.06
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income $19.3M, EPS −$0.06
- Quarter ended Sep 30, 2024: revenue n/a, net income −$2.85M, EPS −$0.06
- Quarter ended Jun 30, 2024: revenue n/a, net income −$2.63M, EPS −$0.05
- Quarter ended Mar 31, 2024: revenue n/a, net income −$2.75M, EPS −$0.06
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income $15.1M, EPS −$0.04
- Quarter ended Sep 30, 2023: revenue $1.00M, net income −$723K, EPS −$0.01
- Quarter ended Jun 30, 2023: revenue n/a, net income −$2.87M, EPS −$0.06
- Quarter ended Mar 31, 2023: revenue n/a, net income −$2.92M, EPS −$0.06
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$3.00M, EPS −$0.07
- Quarter ended Sep 30, 2022: revenue n/a, net income −$3.65M, EPS −$0.07
- Quarter ended Jun 30, 2022: revenue n/a, net income −$4.03M, EPS −$0.08
- Quarter ended Mar 31, 2022: revenue n/a, net income −$3.39M, EPS −$0.07
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$2.08M, EPS −$0.05
- Quarter ended Sep 30, 2021: revenue $37.5K, net income −$3.58M, EPS −$0.07
MNOV cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$9.81M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$10.6M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$7.43M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$12.9M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$9.38M, share buybacks n/a
MNOV balance sheet
- Jun 30, 2026: cash $25.4M, total assets $40.4M, total liabilities $3.16M, shareholders' equity $37.3M
- Mar 31, 2026: cash $27.3M, total assets $42.7M, total liabilities $3.30M, shareholders' equity $39.4M
- Dec 31, 2025: cash $30.8M, total assets $45.6M, total liabilities $4.02M, shareholders' equity $41.6M
- Sep 30, 2025: cash $32.6M, total assets $47.6M, total liabilities $3.61M, shareholders' equity $44.0M
- Jun 30, 2025: cash $34.3M, total assets $49.8M, total liabilities $2.97M, shareholders' equity $46.9M
- Mar 31, 2025: cash $36.6M, total assets $52.4M, total liabilities $2.50M, shareholders' equity $49.9M
- Dec 31, 2024: cash $40.4M, total assets $55.9M, total liabilities $3.37M, shareholders' equity $52.5M
- Sep 30, 2024: cash $42.3M, total assets $58.1M, total liabilities $3.05M, shareholders' equity $55.1M
What is MNOV's revenue?
MEDICINOVA INC reported $410K of revenue for the fiscal year ended December 2025.
Is MNOV profitable?
Yes. MEDICINOVA INC earned $13.2M over the last four quarters.
What is MNOV's EPS?
Diluted earnings per share over the last four quarters were −$0.21; −$0.05 in the latest quarter.